S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
Log in

Seres Therapeutics News Headlines (NASDAQ:MCRB)

$3.46
-0.01 (-0.29 %)
(As of 10/21/2019 04:00 PM ET)
Today's Range
$3.44
Now: $3.46
$3.58
50-Day Range
$2.89
MA: $3.61
$4.03
52-Week Range
$2.02
Now: $3.46
$9.00
Volume151,000 shs
Average Volume404,526 shs
Market Capitalization$241.90 million
P/E RatioN/A
Dividend YieldN/A
Beta1.81

Headlines

Seres Therapeutics (NASDAQ MCRB) News Headlines

Source:
DateHeadline
$6.69 Million in Sales Expected for Seres Therapeutics Inc (NASDAQ:MCRB) This Quarter$6.69 Million in Sales Expected for Seres Therapeutics Inc (NASDAQ:MCRB) This Quarter
www.americanbankingnews.com - October 21 at 2:46 AM
-$0.26 Earnings Per Share Expected for Seres Therapeutics Inc (NASDAQ:MCRB) This Quarter-$0.26 Earnings Per Share Expected for Seres Therapeutics Inc (NASDAQ:MCRB) This Quarter
www.americanbankingnews.com - October 19 at 3:16 PM
Seres Therapeutics Inc (NASDAQ:MCRB) Short Interest Up 10.9% in SeptemberSeres Therapeutics Inc (NASDAQ:MCRB) Short Interest Up 10.9% in September
www.americanbankingnews.com - October 16 at 10:32 PM
Seres Therapeutics Inc (NASDAQ:MCRB) Given Average Recommendation of "Buy" by AnalystsSeres Therapeutics Inc (NASDAQ:MCRB) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - September 30 at 3:29 AM
 Analysts Anticipate Seres Therapeutics Inc (NASDAQ:MCRB) Will Announce Quarterly Sales of $6.69 Million Analysts Anticipate Seres Therapeutics Inc (NASDAQ:MCRB) Will Announce Quarterly Sales of $6.69 Million
www.americanbankingnews.com - September 29 at 8:36 AM
-$0.26 EPS Expected for Seres Therapeutics Inc (NASDAQ:MCRB) This Quarter-$0.26 EPS Expected for Seres Therapeutics Inc (NASDAQ:MCRB) This Quarter
www.americanbankingnews.com - September 27 at 2:24 AM
What's The Cash Runway For Seres Therapeutics, Inc. (NASDAQ:MCRB)?What's The Cash Runway For Seres Therapeutics, Inc. (NASDAQ:MCRB)?
finance.yahoo.com - September 21 at 12:28 AM
Seres Therapeutics, Inc. (MCRB) Shares March Higher, Can It Continue?Seres Therapeutics, Inc. (MCRB) Shares March Higher, Can It Continue?
finance.yahoo.com - August 22 at 11:25 PM
Edited Transcript of MCRB earnings conference call or presentation 6-Aug-19 12:00pm GMTEdited Transcript of MCRB earnings conference call or presentation 6-Aug-19 12:00pm GMT
finance.yahoo.com - August 10 at 8:11 PM
Microbiome biotechs grapple with how to protect their IPMicrobiome biotechs grapple with how to protect their IP
finance.yahoo.com - August 8 at 9:04 AM
Seres Therapeutics, Inc. (MCRB) CEO Eric Shaff on Q2 2019 Results - Earnings Call TranscriptSeres Therapeutics, Inc. (MCRB) CEO Eric Shaff on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 7 at 12:02 AM
Seres Therapeutics (MCRB) Reports Q2 Loss, Tops Revenue EstimatesSeres Therapeutics (MCRB) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - August 7 at 12:02 AM
Seres Therapeutics Inc (MCRB) Q2 2019 Earnings Call TranscriptSeres Therapeutics Inc (MCRB) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 7 at 12:02 AM
Seres Therapeutics EPS beats by $0.24, beats on revenueSeres Therapeutics EPS beats by $0.24, beats on revenue
seekingalpha.com - August 6 at 8:57 AM
Seres Therapeutics Reports Second Quarter Financial Results and Provides Progress UpdateSeres Therapeutics Reports Second Quarter Financial Results and Provides Progress Update
finance.yahoo.com - August 6 at 8:57 AM
Seres Therapeutics Appoints Stephen Berenson to its Board of DirectorsSeres Therapeutics Appoints Stephen Berenson to its Board of Directors
finance.yahoo.com - August 6 at 8:57 AM
Seres Therapeutics to Present at the Canaccord Genuity 39th Annual Growth ConferenceSeres Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference
www.benzinga.com - August 1 at 8:50 AM
Seres Therapeutics (MCRB) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseSeres Therapeutics (MCRB) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
finance.yahoo.com - July 26 at 7:26 AM
What Kind Of Shareholders Own Seres Therapeutics, Inc. (NASDAQ:MCRB)?What Kind Of Shareholders Own Seres Therapeutics, Inc. (NASDAQ:MCRB)?
finance.yahoo.com - June 22 at 6:40 PM
Do Directors Own Seres Therapeutics, Inc. (NASDAQ:MCRB) Shares?Do Directors Own Seres Therapeutics, Inc. (NASDAQ:MCRB) Shares?
finance.yahoo.com - June 22 at 6:40 PM
Seress investigational candidates unaffected by FDA alertSeres's investigational candidates unaffected by FDA alert
seekingalpha.com - June 19 at 8:33 AM
Seres Therapeutics Issues Statement Regarding U.S. Food and Drug Administration Safety Alert Related to Use of Fecal Microbiota TransplantationSeres Therapeutics Issues Statement Regarding U.S. Food and Drug Administration Safety Alert Related to Use of Fecal Microbiota Transplantation
finance.yahoo.com - June 19 at 8:33 AM
Seres Therapeutics prices stock offeringSeres Therapeutics prices stock offering
seekingalpha.com - June 14 at 8:34 AM
Seres Therapeutics, Inc. Announces Proposed Public Offering of Common StockSeres Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
finance.yahoo.com - June 12 at 5:53 PM
Seres Therapeutics (MCRB) Presents At Jefferies 2019 Healthcare Conference Presentation - SlideshowSeres Therapeutics (MCRB) Presents At Jefferies 2019 Healthcare Conference Presentation - Slideshow
seekingalpha.com - June 6 at 7:16 PM
Seres Therapeutics to Present at the Jefferies 2019 Healthcare ConferenceSeres Therapeutics to Present at the Jefferies 2019 Healthcare Conference
finance.yahoo.com - May 29 at 7:02 PM
The Daily Biotech Pulse: Further Delay in Roches Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On EarningsThe Daily Biotech Pulse: Further Delay in Roche's Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings
feeds.benzinga.com - May 14 at 7:55 AM
Seres Therapeutics (MCRB) CEO Eric Shaff on Q1 2019 Results - Earnings Call TranscriptSeres Therapeutics (MCRB) CEO Eric Shaff on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 6 at 8:13 AM
Edited Transcript of MCRB earnings conference call or presentation 2-May-19 12:30pm GMTEdited Transcript of MCRB earnings conference call or presentation 2-May-19 12:30pm GMT
finance.yahoo.com - May 3 at 7:21 PM
Seres Therapeutics (MCRB) Reports Q1 Loss, Lags Revenue EstimatesSeres Therapeutics (MCRB) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 2 at 8:04 PM
Seres Therapeutics, Inc. to Host Earnings CallSeres Therapeutics, Inc. to Host Earnings Call
www.baystreet.ca - May 2 at 8:19 AM
Seres Therapeutics Reports First Quarter Financial Results andProvides Clinical Pipeline Progress UpdateSeres Therapeutics Reports First Quarter Financial Results andProvides Clinical Pipeline Progress Update
www.marketwatch.com - May 2 at 8:19 AM
Seres Therapeutics to Host First Quarter 2019 Financial Results and Operational Progress Conference Call and Webcast on May 2, 2019Seres Therapeutics to Host First Quarter 2019 Financial Results and Operational Progress Conference Call and Webcast on May 2, 2019
finance.yahoo.com - April 29 at 6:47 PM
Seres Therapeutics Presents New Preclinical Data Supporting the Development of SER-401 for Immuno-Oncology at the 2019 American Association for Cancer Research Annual MeetingSeres Therapeutics Presents New Preclinical Data Supporting the Development of SER-401 for Immuno-Oncology at the 2019 American Association for Cancer Research Annual Meeting
finance.yahoo.com - April 2 at 10:00 PM
Seres Therapeutics Inc.Seres Therapeutics Inc.
www.barrons.com - March 27 at 7:54 PM
MTIG Position Statement for FMT - PRNewswireMTIG Position Statement for FMT - PRNewswire
www.prnewswire.com - March 16 at 8:23 AM
Heres Why Seres Therapeutics Stock Soared TodayHere's Why Seres Therapeutics Stock Soared Today
finance.yahoo.com - March 11 at 7:47 PM
Seres Therapeutics (MCRB) CEO Eric Shaff on Q4 2018 Results - Earnings Call TranscriptSeres Therapeutics' (MCRB) CEO Eric Shaff on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 7 at 8:28 AM
Edited Transcript of MCRB earnings conference call or presentation 6-Mar-19 1:30pm GMTEdited Transcript of MCRB earnings conference call or presentation 6-Mar-19 1:30pm GMT
finance.yahoo.com - March 7 at 8:28 AM
Seres Therapeutics Inc (MCRB) Q4 2018 Earnings Conference Call Transcript - Motley FoolSeres Therapeutics Inc (MCRB) Q4 2018 Earnings Conference Call Transcript - Motley Fool
www.fool.com - March 6 at 7:40 PM
Seres Therapeutics Inc (MCRB) Q4 2018 Earnings Conference Call TranscriptSeres Therapeutics Inc (MCRB) Q4 2018 Earnings Conference Call Transcript
www.fool.com - March 6 at 12:16 PM
Seres Therapeutics Reports Fourth Quarter and Full Year Financial Results and Provides Operational UpdatesSeres Therapeutics Reports Fourth Quarter and Full Year Financial Results and Provides Operational Updates
finance.yahoo.com - March 6 at 8:21 AM
Seres Therapeutics to Host Fourth Quarter and Full Year 2018 Financial Results and Operational Progress Conference Call and Webcast on March 6, 2019Seres Therapeutics to Host Fourth Quarter and Full Year 2018 Financial Results and Operational Progress Conference Call and Webcast on March 6, 2019
finance.yahoo.com - March 4 at 8:04 PM
Seres Therapeutics to cut 30% of workforce in restructuringSeres Therapeutics to cut 30% of workforce in restructuring
seekingalpha.com - February 7 at 6:47 PM
Seres Therapeutics Announces Corporate Changes to Focus on Advancing Clinical AssetsSeres Therapeutics Announces Corporate Changes to Focus on Advancing Clinical Assets
finance.yahoo.com - February 7 at 6:47 PM
Form 8-K Seres Therapeutics, Inc. For: Jan 13 - StreetInsider.comForm 8-K Seres Therapeutics, Inc. For: Jan 13 - StreetInsider.com
www.streetinsider.com - January 16 at 8:14 AM
Seres Therapeutics Announces Chief Executive Officer Transition - Business WireSeres Therapeutics Announces Chief Executive Officer Transition - Business Wire
www.businesswire.com - January 16 at 8:14 AM
Seres Therapeutics appoints new CEOSeres Therapeutics appoints new CEO
seekingalpha.com - January 15 at 8:12 AM
Seres Therapeutics Announces Chief Executive Officer TransitionSeres Therapeutics Announces Chief Executive Officer Transition
finance.yahoo.com - January 15 at 8:12 AM
Does Seres Therapeutics, Inc.’s (NASDAQ:MCRB) CEO Salary Compare Well With Others?Does Seres Therapeutics, Inc.’s (NASDAQ:MCRB) CEO Salary Compare Well With Others?
finance.yahoo.com - January 4 at 5:48 PM
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel